Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3

H Rauer and S Grissmer

Department of Applied Physiology, University of Ulm, Germany.

We characterized the action of verapamil and N-methyl-verapamil on current through the delayed-rectifier potassium channel Kv1.3 mouse (mKv1.3). The whole-cell and inside-out configuration of the patch- clamp technique was used to examine the channel properties after injection of in vitro transcribed cRNA into rat basophilic leukemia cells. The action of verapamil on current through mKv1.3 channels could be separated into an acceleration of the rate of current decay during depolarizing pulses and a reduction of steady state peak current when applied either extracellularly or intracellularly. Both effects were greatly reduced when the membrane-impermeable N-methyl-verapamil was applied extracellularly, but it affected current through mKv1.3 channels similar to verapamil if applied to the intracellular side of the membrane. Mutations in the outer vestibule of the mKv1.3 channel did not change the ability of verapamil to accelerate the mKv1.3 current decay during depolarizing pulses, whereas the reduction of the steady state peak current by verapamil applied either extracellularly and intracellularly and by N-methyl-verapamil applied intracellularly was decreased approximately 25-fold in all three cases. Substances known to interact with an extracellular site of the channel (e.g., extracellularly applied tetraethylammonium or kaliotoxin) did not compete with extracellularly applied verapamil on blocking steady state peak current, whereas intracellularly applied tetraethylammonium, which is known to interact with an intracellular site of the channel, was able to reduce the effect of extracellularly applied verapamil on blocking steady state peak current, suggesting competition for a common binding site between verapamil and intracellularly applied tetraethylammonium. The results from the competition experiments as well as from the mutations in the outer vestibule of mKv1.3 are compatible with the idea that verapamil applied extracellularly moves through the membrane to reach its internal binding site on the mKv1.3 channel.

Volume 50, Issue 6, pp. 1625-1634, 12/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				I. Zahradnik, I. Minarovic, and A. Zahradnikova Inhibition of the Cardiac L-Type Calcium Channel Current by Antidepressant Drugs J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 977 - 984. [Abstract] [Full Text] [PDF]

				C. Pimentel, S. M'Barek, V. Visan, S. Grissmer, F. Sampieri, J.-M. Sabatier, H. Darbon, and Z. Fajloun Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins Protein Sci., January 1, 2008; 17(1): 107 - 118. [Abstract] [Full Text] [PDF]

				A. Rossokhin, G. Teodorescu, S. Grissmer, and B. S. Zhorov Interaction of d-Tubocurarine with Potassium Channels: Molecular Modeling and Ligand Binding Mol. Pharmacol., April 1, 2006; 69(4): 1356 - 1365. [Abstract] [Full Text] [PDF]

				S. Mouhat, G. Teodorescu, D. Homerick, V. Visan, H. Wulff, Y. Wu, S. Grissmer, H. Darbon, M. De Waard, and J.-M. Sabatier Pharmacological Profiling of Orthochirus scrobiculosus Toxin 1 Analogs with a Trimmed N-Terminal Domain Mol. Pharmacol., January 1, 2006; 69(1): 354 - 362. [Abstract] [Full Text] [PDF]

				T. Dreker and S. Grissmer Investigation of the Phenylalkylamine Binding Site in hKv1.3 (H399T), a Mutant with a Reduced C-Type Inactivated State Mol. Pharmacol., October 1, 2005; 68(4): 966 - 973. [Abstract] [Full Text] [PDF]

				V. Visan, Z. Fajloun, J.-M. Sabatier, and S. Grissmer Mapping of Maurotoxin Binding Sites on hKv1.2, hKv1.3, and hIKCa1 Channels Mol. Pharmacol., November 1, 2004; 66(5): 1103 - 1112. [Abstract] [Full Text] [PDF]

				M. Brauer, E. Frei, L. Claes, S. Grissmer, and H. Jager Influence of K-Cl cotransporter activity on activation of volume-sensitive Cl- channels in human osteoblasts Am J Physiol Cell Physiol, July 1, 2003; 285(1): C22 - C30. [Abstract] [Full Text] [PDF]

				K. Hirota, E. Hashiba, H. Yoshioka, S. Kabara, and A. Matsuki Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation Br. J. Anaesth., May 1, 2003; 90(5): 671 - 675. [Abstract] [Full Text] [PDF]

				V. V. Artym and H. R. Petty Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and {beta}1-Integrins on the Plasma Membrane of Melanoma Cells: Effects of Cell Adherence and Channel Blockers J. Gen. Physiol., June 10, 2002; 120(1): 29 - 38. [Abstract] [Full Text] [PDF]

				V. Rybalchenko, N. Prevarskaya, F. Van Coppenolle, G. Legrand, L. Lemonnier, X. Le Bourhis, and R. Skryma Verapamil Inhibits Proliferation of LNCaP Human Prostate Cancer Cells Influencing K+ Channel Gating Mol. Pharmacol., June 1, 2001; 59(6): 1376 - 1387. [Abstract] [Full Text]

				C. Beeton, J. Barbaria, P. Giraud, J. Devaux, A.-M. Benoliel, M. Gola, J. M. Sabatier, D. Bernard, M. Crest, and E. Beraud Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation J. Immunol., January 15, 2001; 166(2): 936 - 944. [Abstract] [Full Text] [PDF]

				H. Rauer, M. D. Lanigan, M. W. Pennington, J. Aiyar, S. Ghanshani, M. D. Cahalan, R. S. Norton, and K. G. Chandy Structure-guided Transformation of Charybdotoxin Yields an Analog That Selectively Targets Ca2+-activated over Voltage-gated K+ Channels J. Biol. Chem., January 14, 2000; 275(2): 1201 - 1208. [Abstract] [Full Text] [PDF]

				H. Rauer, M. Pennington, M. Cahalan, and K. G. Chandy Structural Conservation of the Pores of Calcium-activated and Voltage-gated Potassium Channels Determined by a Sea Anemone Toxin J. Biol. Chem., July 30, 1999; 274(31): 21885 - 21892. [Abstract] [Full Text] [PDF]

				R. C. Hogg, C. Trequattrini, L. Catacuzzeno, A. Petris, F. Franciolini, and D. J. Adams Mechanisms of Verapamil Inhibition of Action Potential Firing in Rat Intracardiac Ganglion Neurons J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1502 - 1508. [Abstract] [Full Text]

				C. Chouabe, M.-D. Drici, G. Romey, J. Barhanin, and M. Lazdunski HERG and KvLQT1/IsK, the Cardiac K+ Channels Involved in Long QT Syndromes, Are Targets for Calcium Channel Blockers Mol. Pharmacol., October 1, 1998; 54(4): 695 - 703. [Abstract] [Full Text]

				A. Wrisch and S. Grissmer Structural Differences of Bacterial and Mammalian K+ Channels J. Biol. Chem., December 8, 2000; 275(50): 39345 - 39353. [Abstract] [Full Text] [PDF]